Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of PH3 in Diabetic Nephropathy (PH3)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
PhytoHealth Corporation
ClinicalTrials.gov Identifier:
NCT01068041
First received: February 11, 2010
Last updated: November 3, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)